Theralase Technologies Inc. (TLT) | Finanzwire

Basculer en Français

8304	Companies
115195	Keywords
55510	Articles
62563	Press releases

Headlines Articles Press releases Theralase Technologies Inc.

Home
Companies
Theralase Technologies Inc.

PRESS RELEASE

published on 11/30/2023 at 00:30, 11 months 22 days ago

Theralase Release’s 3Q2023 Interim Financial Statements
Theralase Technologies Inc. has released the Company's 3Q2023 unaudited condensed interim consolidated Financial Statements, showing a 13% decrease in total revenue and other significant financial highlights

Financial Statements Theralase Technologies Inc. Clinical Research 3Q2023 Revenue Decrease
PRESS RELEASE

published on 11/29/2023 at 22:35, 11 months 22 days ago

Theralase(R) Closes $CAN 1.17 Million Non-Brokered Private Placement
PRESS RELEASE

published on 11/17/2023 at 22:30, 1 year ago

Theralase(R) Commences Non-Brokered Private Placement and Termination of Previously Announced Financing
PRESS RELEASE

published on 10/23/2023 at 23:55, 1 year ago

Theralase(R) Announces Brokered LIFE Financing
PRESS RELEASE

published on 10/23/2023 at 13:00, 1 year ago

Theralase(R) Optimizes Phase II Bladder Cancer Clinical Study
PRESS RELEASE

published on 10/16/2023 at 13:00, 1 year 1 month ago

Theralase(R) Provides Update on Bladder Cancer Clinical Study
PRESS RELEASE

published on 10/05/2023 at 13:00, 1 year 1 month ago

Theralase(R) Files US Patent for Enhanced Immunotherapy
PRESS RELEASE

published on 09/29/2023 at 13:00, 1 year 1 month ago

Theralase(R) Demonstrates 8 Year Shelf Life of Lead Drug Ruvidar(TM)
PRESS RELEASE

published on 09/27/2023 at 13:00, 1 year 1 month ago

Theralase(R) Successfully Completes Non-GLP Toxicity Analysis for Brain Cancer
PRESS RELEASE

published on 09/21/2023 at 22:35, 1 year 2 months ago

Theralase(R) Grants Stock Options

Accesswire

Published on 11/22/2024 at 09:00, 1 hour 49 minutes ago

Industrial Software Company mlean Celebrates 10 Years of Continuous Improvement
Published on 11/22/2024 at 00:00, 10 hours 49 minutes ago

Gratomic Announces Company and Operational Update
Published on 11/21/2024 at 22:05, 12 hours 44 minutes ago

Protagonist Announces Nomination of PN-881, a Potential Best-in-Class Oral Peptide IL-17 Antagonist Development Candidate
Published on 11/21/2024 at 21:50, 12 hours 59 minutes ago

Seventy Ninth Resources Announces Successful First Reconnaissance at McKellar Copper-Zinc and Enable Gold Projects
Published on 11/21/2024 at 20:15, 14 hours 34 minutes ago

Woodland Park Zoo Awarded Transformative Grant to Advance Empathy for Animals

View all ACCESSWIRE

EQS Group

Published on 11/22/2024 at 09:45, 1 hour 4 minutes ago

The GSMA – China Unicom Open Gateway Global Use Case Innovation Challenge has begun!
Published on 11/22/2024 at 09:23, 1 hour 26 minutes ago

Turkiye Garanti Bankasi A.S.: Announcement regarding issuance of subordinated notes
Published on 11/22/2024 at 09:06, 1 hour 43 minutes ago

Original-Research: NFON AG (von NuWays AG): Buy
Published on 11/22/2024 at 09:05, 1 hour 44 minutes ago

Amundi Physical Metals plc: UK Final Terms
Published on 11/22/2024 at 09:03, 1 hour 46 minutes ago

Amundi Physical Metals plc: UK Final Terms

Les Echos

Published on 11/21/2024 at 06:58, 1 day 3 hours ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 1 day 15 hours ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 1 day 17 hours ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 1 day 17 hours ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 2 days 3 hours ago

Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo

View all LES ECHOS COMFI WIRE